June 21,2022

Mr Ashish Maheshwari, Chairman & Managing Director, interacts with Dalal Street Investment Journal (DSIJ)

We are targeting a strong global presence over the next five years by using a judicious mix of manufactured and outsourced supply chains to emerge as the leader in branded, IPR-driven pharma products in global frontier markets; elucidates Ashish Maheshwari

December 10,2020

Mr Ashish Maheshwari, Chaiman & MD, interacts with Indiainfoline

Our Chairman & MD speaks about Balaxi and its strategy in an interaction with Indiainfoline.com...

October 12,2020

Balaxi Pharmaceuticals reports revenue of INR 1,124 million in H1 FY21

Balaxi announced its results for the quarter and half year ended 30th September 2020.

October 07,2020

Balaxi Ventures Limited renamed as Balaxi Pharmaceuticals Limited

The MCA has granted approval to the change in the company’s name...